Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RBP4 antagonists for treatment and prevention of non-alcoholic fatty liver disease and gout

RBP4 antagonists for treatment and prevention of non-alcoholic fatty liver disease and gout

US Patent 12440486 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-phenylpiperidines, their preparation and use2025
Substituted 4-phenylpiperidines, their preparation and use2025
Triazolopyrimidines, their preparation and use2024
Triazolopyrimidines, their preparation and use2024
Triazolopyrimidines, their preparation and use2024
Methods of treating RBP4 related diseases with triazolopyridines2024
4-phenylpiperidines, their preparation and use2024
Substituted 4-phenylpiperidines, their preparation and use2023
Oral pyrophosphate for use in reducing tissue calcification2022
Mitragynine analogs and uses thereof2021
4-phenylpiperidines, their preparation and use2021
Fluorenone compound for the treatment of gout2021